Invasive testing Ostrava, Olomouc - Ishraq Dhaifalah - Centre of Fetal Medicine and Human Genetics Ostrava, Olomouc Ishraq Dhaifalah - Centre of Fetal Medicine and Human Genetics Ostrava, Olomouc

polsky
english
czech

Invasive testing usually follows positive screening for chromosomal defects (see Screening for chromosomal defects of the fetus) and is sometimes performed for other indications such as a presence of a genetic or hereditary chromosomal defect in the family and so on. Invasive test is in a present time the only method which can with certainty confirm or exclude a chromosomal defect in a fetus. All the other methods only calculate a risk of a presence of a chromosomal abnormality in a fetus. There are two most frequently used methods of invasive testing - chorionic villous sampling and amniocentesis.

When a chromosomal defect is confirmed by the invasive testing or a genetic defect is found, the result is conveyed to the parents during genetic consultation. We explain the nature of the disability and the prognosis for the fetus. There is no way of changing or removing a chromosomal or a genetic defect in a fetus. The purpose of the consultation is to explain all the consequences and to enable the parents to decide on the path they want to take. If the prognosis for the fetus is very unfavourable, it is possible to terminate the pregnancy on the basis of genetic indication until the 24th week of gestation. The decision on the fate of the pregnancy belongs to the parents and we always respect their decision.

FETMED s.r.o.

FacebookOSTRAVA - Dr. Martínka 7, 700 30 Ostrava – Hrabůvka, Czech Republic
tel.: +420 773 190 249, fetmed@seznam.cz

OLOMOUC - Horní Lán 1200/13, 779 00 Olomouc, Czech Republic
tel.: +420 605 825 780, fetmed.ol@seznam.cz

Links    Webdesign STUDIO VIRTUALIS